NEW BRUNSWICK, N.J., June 3, 2005 /PRNewswire-FirstCall via COMTEX/ -- Johnson & Johnson (NYSE: JNJ) today announced the completion of its previously announced acquisition of CLOSURE Medical Corporation, a global leader in biomaterial-based devices.
Johnson & Johnson is the world's most comprehensive and broadly based manufacturer of health care products, as well as a provider of related services, for the consumer, pharmaceutical, and medical devices and diagnostics markets. The more than 200 Johnson & Johnson operating companies employ approximately 111,000 men and women in 57 countries and sell products throughout the world.
SOURCE Johnson & Johnson
Media - Marc Monseau, +1-732-524-1130 or Investor - Helen E. Short, +1-732-524-6491, or Stan Panasewicz, +1-732-524-2524, all of Johnson & Johnson
Copyright (C) 2005 PR Newswire. All rights reserved.
News Provided by COMTEX